Science Education & Policy
Newswire |
BASINGSTOKE, England and PHILADELPHIA, April 25 /PRNewswire/ --
- All Figures are in US$
Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company announces results for the three months to March 31, 2008.
Q1 2008 Financial Highlights - Product sales up 37% to $632m - New product sales(1) $216m, 34% of product sales (2007: 13%) - Total revenues up 33% to $702m - US GAAP Operating income up 15% to $163m - Non GAAP Operating income up 23% to $192m - US GAAP Earnings per ADS up 7% to $0.68 - Non GAAP Earnings per ADS up 5% to $0.74
(1) New product sales include DAYTRANA…
It's been just over three years since I got married, and I remember thinking (amid the nearly debilitating fear that we would run out of alcohol at our mountain cabin wedding and thus trap our families in a scene from The Shining) that it would be wonderful to finally be free forever from the intrigue and confusion of dating.
You can't fault the optimism.
Now, through the lens of hindsight, I realize that I should have known that dating and even cohabitating were only warm-ups for the big dance.
Example: I didn't really mind the eggshell color of our living room walls——it provided a…
Advance directives, or living wills, may not effectively honor end-of-life wishes because life-sustaining treatment preferences often change without people being aware of the changes, according to a new study co-authored by UC Irvine researchers Peter Ditto and Elizabeth Loftus.
False memories can play a significant role in the discrepancy between an individual's true preferences for end-of-life treatment and what is instructed in their living will. Life-sustaining treatment preferences often change as people age or experience new health problems, and advance directive forms typically remind…
Newswire |
COLLEGEVILLE, Pennsylvania and TARRYTOWN, New York, April 24 /PRNewswire/ --
- Final Decision from European Commission Expected by Mid-2008
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), today announced that the companies have received a positive opinion for RELISTOR(TM) (methylnaltrexone bromide) subcutaneous injection from the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA). The companies are seeking the approval of RELISTOR in Europe for the treatment of…
Newswire |
BASINGSTOKE, England, April 24 /PRNewswire/ -- The Board of Directors of Shire plc (LSE: SHP) (NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces today that Michael Rosenblatt M.D. will join the Board as a Non-Executive Director with immediate effect.
Dr Rosenblatt is the Dean of Tufts University School of Medicine, Boston, Massachusetts. He was previously Professor of Medicine at Harvard Medical School and has served in senior research positions at the Beth Israel Deaconess Medical Center in Boston. He was the founding director of the Carl J. Shapiro Institute for…
Newswire |
ZUG, Switzerland, April 24 /PRNewswire/ -- Swiss Hawk AG's portfolio company CleanAir Technologies AB ("CleanAir") has announced that it has secured a EUR 5.6 million project contract with Energi Randers, Denmark. Energi Randers has given CleanAir an order to install systems for: flue gas cleaning and condensation, combustion air humidification and also waste water treatment. All these systems will improve the economical and environmental capacity of their new plant for bio fuel and coal burning. The power of the system is 2 x 90 MW. The work will be finalised during 2009.
"A combined system…
A much-discussed idea to offset global warming by injecting sulfate particles into the stratosphere would have a drastic impact on Earth's protective ozone layer, new research concludes. The study, led by Simone Tilmes of the National Center for Atmospheric Research (NCAR), warns that such an approach might delay the recovery of the Antarctic ozone hole by decades and cause significant ozone loss over the Arctic.
The study will be published Thursday in Science Express. It was funded by the National Science Foundation, which is NCAR's principal sponsor, as well as by NASA and European funding…
Newswire |
BASINGSTOKE, England and PHILADELPHIA, April 23 /PRNewswire/ --
- Within the First Eight Months Since its Introduction in the United States, VYVANSE has Achieved Over One Million Prescriptions
- In a Clinical Study With Adults, VYVANSE was Shown to Significantly Improve the Symptoms of ADHD (Inattention, Hyperactivity and Impulsivity)(1)
Shire plc (LSE: SHP) (NASDAQ: SHPGY,), the global specialty biopharmaceutical company, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for VYVANSE(TM) (lisdexamfetamine dimesylate), for the treatment of…
Newswire |
CHICAGO and BEDMINSTER, New Jersey, April 23 /PRNewswire/ --
Rosenthal Collins Group, LLC (RCG), a leading independent futures clearing firm, and GAIN Capital Group LLC, a market leader in retail foreign exchange (forex) trading, today announced they are joining forces to establish operations in the United Kingdom. The new entity, to be known as RCG GAIN Limited, will offer online trading capabilities in forex and futures to self-directed investors in the UK, with the intention to expand the trading service further into the European Union over time. The venture has received regulatory…
Newswire |
SAN FRANCISCO, April 23 /PRNewswire/ --
The Messaging Anti-Abuse Working Group (MAAWG) has released version 2.0 of its Senders Best Communications Practices defining how volume email senders can improve the deliverability of legitimate e-newsletters and permission-based e-marketing. The recommendations, originally issued last year as one of the first collaborative efforts between network operators and volume senders worldwide, has been updated to address new forms of spam and to clarify permission options.
(Logo: http://www.newscom.com/cgi-bin/prnh/20070124/CLW180LOGO )
Available today at…